Investments
Clinical Candidates
Over ten GHIT development partnerships have conducted clinical programs worldwide.
Please see
each program to know more details.
-
-
Tuberculosis / Diagnostics
Lung Flute ECO -
-
- Development Stage: Product Validation
- Country: Cameroon
-
-
-
-
-
Malaria / Vaccine
AnAPN1 -
-
- Development Stage: Phase I Clinical Trial
- Country: Gabon (Planned)
-
-
Photo credit: Biopromic AB
-
-
-
Mycetoma / Drug
Fosravuconazole -
-
- Development Stage: Phase III Clinical Trial
- Country: Sudan
-
-
© Purushottam Diwakar-DNDi
-
-
-
Cutaneous leishmaniasis / Drug
CpG-D35 -
-
- Development Stage: Phase I Clinical Trial
- Country: United Kingdom, Colombia
-
-
© Sydelle Willow Smith-DNDi
-
-
-
Lymphatic filariasis, Onchocerciasis / Drug
AWZ1066S -
-
- Development Stage: Phase I Clinical Trial
- Country: United Kingdom, Cameroon (planned)
-
-
Photo credit: Kate Dodd
-
-
-
Buruli Ulcer / Diagnostics
BU-MYCOLAC -
-
- Development Stage: Product Development
- Country: Cameroon, Ivory Coast
-
-
Photo credit: FIND
-
-
-
Chagas disease / Diagnostics
Chagas-LAMP -
-
- Development Stage: Product Validation
- Country: Argentina, Bolivia, Paraguay
-
-
Photo credit: CONICET-INGEBI
-
-
-
Leishmaniasis / Diagnostics
Leishmania Skin Test (LST) -
-
- Development Stage: Product Development
- Country: India and Africa (Planned)
-
-
-
-
-
Schistosomiasis / Diagnostics
SCH CAA RDT -
-
- Development Stage: Product Development
- Country: Kenya, Philippines
-
-
Photo credit: Vinicius Berger-DNDi
-
-
-
Schistosomiasis / Pediatric Drug
Arpraziquantel -
-
- Development Stage: Registration, Access
- Country: Ivory Coast, Kenya, Uganda and other endemic countries.
-
-
Photo credit: SCI Foundation/Uganda
-